The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk. 2022

Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

There is an evidence gap regarding the predictive accuracy of the triglyceride-glucose (TyG) index for long-term major adverse cardiovascular events (MACEs) in individuals with high cardiovascular risk. The aim of this investigation was to evaluate the predictive value of the TyG index for long-term MACEs in patients at high cardiovascular risk. In total, 483 patients with high cardiovascular risk were included in this analysis. The study population was separated into 2 groups depending on the occurrence of long-term MACEs. The independent predictors of long-term MACEs in patients with high cardiovascular risk were investigated. The long-term prognostic value of the TyG index in these patients was evaluated in terms of MACEs. Age, male sex, diabetes mellitus, and the TyG index were demonstrated to be independent predictors of long-term MACE occurrence in patients with high cardiovascular risk. The TyG index was independently related to long-term MACEs in patients with high cardiovascular risk (hazard ratio, 1.003; 95% confidence interval [CI], 1.001-1.006; p=0.011). The receiver operating characteristic curve revealed that the optimum value of the TyG index to predict long-term MACEs in the overall study cohort was >9.68, with 65% sensitivity and 63% specificity (area under the curve, 0.71; 95% CI, 0.65-0.77; p<0.001). The TyG index was demonstrated to be an independent predictor of long-term MACE occurrence in patients with high cardiovascular risk who had not been previously diagnosed with cardiovascular disease.

UI MeSH Term Description Entries

Related Publications

Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
March 2023, Angiology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
March 2024, International urology and nephrology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
May 2024, International heart journal,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
January 2024, Angiology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
August 2022, Cardiovascular diabetology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
June 2020, Cardiovascular diabetology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
October 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
November 2023, Cardiovascular diabetology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
October 2023, Cardiovascular diabetology,
Mert İlker Hayıroğlu, and Tufan Çınar, and Vedat Çiçek, and Ali Palice, and Görkem Ayhan, and Ahmet İlker Tekkeşin
January 2021, Frontiers in endocrinology,
Copied contents to your clipboard!